TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs2943634
log Bayes Factor = 9.19169
Chromosome 2   position 227,068,080  (GRCh37) Explore rs2943634 on Ensembl!
Variant rs2943634 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E11.9 Without complications
0.000 0.000 1.000
E11 Non-insulin-dependent diabetes mellitus
0.000 0.307 0.693
E11.3 With ophthalmic complications
0.000 0.350 0.650
E10-E14 Diabetes mellitus
0.000 0.432 0.568
E11.8 With unspecified complications
0.000 0.448 0.552
E13 Other specified diabetes mellitus
0.000 0.483 0.517
E11.7 With multiple complications
0.000 0.503 0.497
E13.9 Without complications
0.000 0.514 0.486
E10 Insulin-dependent diabetes mellitus
0.000 0.519 0.481
E10.1 With ketoacidosis
0.000 0.536 0.464
E11.5 With peripheral circulatory complications
0.000 0.561 0.439
E11.0 With coma
0.000 0.566 0.434
E11.6 With other specified complications
0.000 0.584 0.416
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.000 0.590 0.410
E12 Malnutrition-related diabetes mellitus
0.000 0.593 0.407
E14 Unspecified diabetes mellitus
0.000 0.593 0.407
E78.0 Pure hypercholesterolaemia
0.000 0.593 0.407
E10.8 With unspecified complications
0.000 0.598 0.402
E78.5 Hyperlipidaemia, unspecified
0.000 0.605 0.395
E11.1 With ketoacidosis
0.000 0.606 0.393
E78.2 Mixed hyperlipidaemia
0.000 0.607 0.393
E14.9 Without complications
0.000 0.626 0.374
E11.4 With neurological complications
0.000 0.627 0.373
E13.8 With unspecified complications
0.000 0.629 0.371
E13.7 With multiple complications
0.000 0.629 0.371
E13.6 With other specified complications
0.000 0.629 0.371
E13.5 With peripheral circulatory complications
0.000 0.629 0.371
E13.4 With neurological complications
0.000 0.629 0.371
E13.2 With renal complications
0.000 0.629 0.371
E13.1 With ketoacidosis
0.000 0.629 0.371
E13.0 With coma
0.000 0.629 0.371
E10.0 With coma
0.000 0.631 0.369
E78.4 Other hyperlipidaemia
0.000 0.642 0.358
E10.9 Without complications
0.000 0.647 0.353
E13.3 With ophthalmic complications
0.000 0.654 0.346
E10.7 With multiple complications
0.000 0.655 0.345
E78.1 Pure hyperglyceridaemia
0.000 0.655 0.345
E11.2 With renal complications
0.000 0.673 0.327
E10.5 With peripheral circulatory complications
0.000 0.678 0.322
E14.8 With unspecified complications
0.000 0.679 0.321
E78.9 Disorder of lipoprotein metabolism, unspecified
0.000 0.681 0.319
E78.8 Other disorders of lipoprotein metabolism
0.000 0.683 0.317
E12.9 Without complications
0.000 0.708 0.292
E12.8 With unspecified complications
0.000 0.708 0.292
E12.7 With multiple complications
0.000 0.708 0.292
E12.6 With other specified complications
0.000 0.708 0.292
E12.5 With peripheral circulatory complications
0.000 0.708 0.292
E12.4 With neurological complications
0.000 0.708 0.292
E12.3 With ophthalmic complications
0.000 0.708 0.292
E12.2 With renal complications
0.000 0.708 0.292
E12.1 With ketoacidosis
0.000 0.708 0.292
E12.0 With coma
0.000 0.708 0.292
E14.7 With multiple complications
0.000 0.708 0.292
E14.5 With peripheral circulatory complications
0.000 0.708 0.292
E14.0 With coma
0.000 0.708 0.292
E10.2 With renal complications
0.000 0.710 0.290
I25.8 Other forms of chronic ischaemic heart disease
0.000 0.711 0.289
E78.3 Hyperchylomicronaemia
0.000 0.711 0.289
E10.6 With other specified complications
0.000 0.712 0.288
I25 Chronic ischaemic heart disease
0.000 0.713 0.287
E14.3 With ophthalmic complications
0.000 0.716 0.284
I25.9 Chronic ischaemic heart disease, unspecified
0.000 0.718 0.282
I25.5 Ischaemic cardiomyopathy
0.000 0.724 0.276
E14.4 With neurological complications
0.000 0.736 0.264
E14.2 Withrenal complications
0.000 0.747 0.253
E78.6 Lipoprotein deficiency
0.000 0.747 0.253
I25.0 Atherosclerotic cardiovascular disease, so described
0.000 0.750 0.250
E10.4 With neurological complications
0.000 0.758 0.242
E14.6 With other specified complications
0.000 0.760 0.240
I25.3 Aneurysm of heart
0.000 0.767 0.233
E10.3 With ophthalmic complications
0.000 0.776 0.224
I25.1 Atherosclerotic heart disease
0.000 0.785 0.215
E14.1 With ketoacidosis
0.001 0.801 0.199
I25.6 Silent myocardial ischaemia
0.000 0.810 0.190
I25.2 Old myocardial infarction
0.000 0.865 0.135
I25.4 Coronary artery aneurysm
0.000 0.866 0.134
T36-T50 Poisoning by drugs, medicaments and biological substances
0.096 0.904 0.000
T50.9 Other and unspecified drugs, medicaments and biological substances
0.094 0.906 0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances
0.094 0.906 0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs
0.093 0.907 0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.091 0.909 0.000
T42.4 Benzodiazepines
0.091 0.909 0.000
I60.9 Subarachnoid haemorrhage, unspecified
0.000 0.910 0.090
I60 Subarachnoid haemorrhage
0.000 0.912 0.088
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]
0.086 0.914 0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system
0.086 0.914 0.000
F20-F29 Schizophrenia, schizotypal and delusional disorders
0.083 0.917 0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified
0.080 0.920 0.000
F20 Schizophrenia
0.079 0.921 0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.079 0.921 0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified
0.079 0.921 0.000
F23 Acute and transient psychotic disorders
0.078 0.922 0.000
I60.3 Subarachnoid haemorrhage from posterior communicating artery
0.000 0.922 0.078
I60.1 Subarachnoid haemorrhage from middle cerebral artery
0.000 0.922 0.078
I60.2 Subarachnoid haemorrhage from anterior communicating artery
0.000 0.923 0.077
F29 Unspecified nonorganic psychosis
0.077 0.923 0.000
T40.2 Other opioids
0.076 0.924 0.000
T47.1 Other antacids and anti-gastric-secretion drugs
0.075 0.925 0.000
T42.0 Hydantoin derivatives
0.075 0.925 0.000
F22 Persistent delusional disorders
0.074 0.926 0.000
F20.0 Paranoid schizophrenia
0.074 0.926 0.000
T40.6 Other and unspecified narcotics
0.074 0.926 0.000
T38.1 Thyroid hormones and substitutes
0.072 0.928 0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs
0.072 0.928 0.000
F25 Schizoaffective disorders
0.071 0.929 0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
0.071 0.929 0.000
F20.9 Schizophrenia, unspecified
0.070 0.930 0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics
0.070 0.930 0.000
I60.8 Other subarachnoid haemorrhage
0.000 0.930 0.070
T42.3 Barbiturates
0.069 0.931 0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants
0.069 0.931 0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries
0.000 0.931 0.069
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system
0.069 0.931 0.000
T41 Poisoning by anaesthetics and therapeutic gases
0.069 0.931 0.000
T40.5 Cocaine
0.069 0.931 0.000
F23.9 Acute and transient psychotic disorder, unspecified
0.069 0.931 0.000
T47.0 Histamine H(2)-receptor antagonists
0.067 0.933 0.000
T50.7 Analeptics and opioid receptor antagonists
0.067 0.933 0.000
T50.5 Appetite depressants
0.067 0.933 0.000
T50.3 Electrolytic, caloric and water-balance agents
0.067 0.933 0.000
T50.1 Loop [high-ceiling] diuretics
0.067 0.933 0.000
T50.0 Mineralocorticoids and their antagonists
0.067 0.933 0.000
T50.4 Drugs affecting uric acid metabolism
0.067 0.933 0.000
T42.5 Mixed antiepileptics, not elsewhere classified
0.067 0.933 0.000
T42.2 Succinimides and oxazolidinediones
0.067 0.933 0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system
0.067 0.933 0.000
T46 Poisoning by agents primarily affecting the cardiovascular system
0.067 0.933 0.000
T36 Poisoning by systemic antibiotics
0.067 0.933 0.000
F22.0 Delusional disorder
0.067 0.933 0.000
T40.1 Heroin
0.066 0.933 0.000
F23.0 Acute polymorphic psychotic disorder without symptoms of schizophrenia
0.066 0.934 0.000
T38.9 Other and unspecified hormone antagonists
0.065 0.934 0.000
T38.8 Other and unspecified hormones and their synthetic substitutes
0.065 0.934 0.000
T38.7 Androgens and anabolic congeners
0.065 0.934 0.000
T38.5 Other oestrogens and progestogens
0.065 0.934 0.000
T38.4 Oral contraceptives
0.065 0.934 0.000
T38.2 Antithyroid drugs
0.065 0.934 0.000
T38.0 Glucocorticoids and synthetic analogues
0.065 0.934 0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics
0.065 0.935 0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified
0.000 0.935 0.065
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation
0.000 0.935 0.065
T50.8 Diagnostic agents
0.064 0.936 0.000
T47.4 Other laxatives
0.064 0.936 0.000
I60.5 Subarachnoid haemorrhage from vertebral artery
0.000 0.936 0.063
T40.9 Other and unspecified psychodysleptics [hallucinogens]
0.062 0.938 0.000
T40.8 Lysergide [LSD]
0.062 0.938 0.000
T40.7 Cannabis (derivatives)
0.062 0.938 0.000
T40.3 Methadone
0.062 0.938 0.000
T40.0 Opium
0.062 0.938 0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.062 0.938 0.000
T47.8 Other agents primarily affecting the gastro-intestinal system
0.062 0.938 0.000
T47.7 Emetics
0.062 0.938 0.000
T47.6 Antidiarrhoeal drugs
0.062 0.938 0.000
T47.5 Digestants
0.062 0.938 0.000
T47.3 Saline and osmotic laxatives
0.062 0.938 0.000
T47.2 Stimulant laxatives
0.062 0.938 0.000
F23.3 Other acute predominantly delusional psychotic disorders
0.061 0.939 0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.060 0.940 0.000
F28 Other nonorganic psychotic disorders
0.059 0.940 0.000
F24 Induced delusional disorder
0.059 0.940 0.000
F21 Schizotypal disorder
0.059 0.940 0.000
T50.6 Antidotes and chelating agents, not elsewhere classified
0.059 0.941 0.000
F25.9 Schizoaffective disorder, unspecified
0.058 0.941 0.000
F22.9 Persistent delusional disorder, unspecified
0.058 0.942 0.000
T42.1 Iminostilbenes
0.058 0.942 0.000
F25.2 Schizoaffective disorder, mixed type
0.058 0.942 0.000
F20.6 Simple schizophrenia
0.057 0.943 0.000
F20.4 Postschizophrenic depression
0.057 0.943 0.000
F20.3 Undifferentiated schizophrenia
0.057 0.943 0.000
F20.2 Catatonic schizophrenia
0.057 0.943 0.000
F20.1 Hebephrenic schizophrenia
0.057 0.943 0.000
I60.4 Subarachnoid haemorrhage from basilar artery
0.000 0.943 0.056
F20.8 Other schizophrenia
0.056 0.944 0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified
0.056 0.944 0.000
F23.8 Other acute and transient psychotic disorders
0.056 0.944 0.000
F23.2 Acute schizophrenia-like psychotic disorder
0.056 0.944 0.000
F23.1 Acute polymorphic psychotic disorder with symptoms of schizophrenia
0.056 0.944 0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.055 0.944 0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.055 0.945 0.000
F25.1 Schizoaffective disorder, depressive type
0.054 0.946 0.000
F22.8 Other persistent delusional disorders
0.053 0.946 0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs
0.053 0.947 0.000
T49.9 Topical agent, unspecified
0.052 0.948 0.000
T49.8 Other topical agents
0.052 0.948 0.000
T49.7 Dental drugs, topically applied
0.052 0.948 0.000
T49.6 Otorhinolaryngological drugs and preparations
0.052 0.948 0.000
T49.5 Ophthalmological drugs and preparations
0.052 0.948 0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.052 0.948 0.000
T49.3 Emollients, demulcents and protectants
0.052 0.948 0.000
T49.2 Local astringents and local detergents
0.052 0.948 0.000
T49.1 Antipruritics
0.052 0.948 0.000
T37.8 Other specified systemic anti-infectives and antiparasitics
0.051 0.949 0.000
F25.8 Other schizoaffective disorders
0.051 0.949 0.000
T36.4 Tetracyclines
0.051 0.949 0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified
0.050 0.950 0.000
T37.5 Antiviral drugs
0.050 0.950 0.000
T37.4 Anthelminthics
0.050 0.950 0.000
T37.3 Other antiprotozoal drugs
0.050 0.950 0.000
T37.2 Antimalarials and drugs acting on other blood protozoa
0.050 0.950 0.000
T37.1 Antimycobacterial drugs
0.050 0.950 0.000
T37.0 Sulphonamides
0.050 0.950 0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified
0.050 0.950 0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified
0.050 0.950 0.000
T46.3 Coronary vasodilators, not elsewhere classified
0.050 0.950 0.000
T41.5 Therapeutic gases
0.049 0.950 0.000
T41.4 Anaesthetic, unspecified
0.049 0.950 0.000
T41.3 Local anaesthetics
0.049 0.950 0.000
T41.2 Other and unspecified general anaesthetics
0.049 0.950 0.000
T41.1 Intravenous anaesthetics
0.049 0.950 0.000
T41.0 Inhaled anaesthetics
0.049 0.950 0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system
0.049 0.950 0.000
T48.6 Antiasthmatics, not elsewhere classified
0.049 0.950 0.000
T48.5 Anti-common-cold drugs
0.049 0.950 0.000
T48.4 Expectorants
0.049 0.950 0.000
T48.3 Antitussives
0.049 0.950 0.000
T48.2 Other and unspecified agents primarily acting on muscles
0.049 0.950 0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.049 0.950 0.000
T48.0 Oxytocic drugs
0.049 0.950 0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified
0.049 0.950 0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system
0.049 0.950 0.000
I60-I69 Cerebrovascular diseases
0.000 0.951 0.049
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified
0.048 0.952 0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.048 0.952 0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.048 0.952 0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified
0.048 0.952 0.000
T44.1 Other parasympathomimetics [cholinergics]
0.048 0.952 0.000
T44.0 Anticholinesterase agents
0.048 0.952 0.000
F25.0 Schizoaffective disorder, manic type
0.048 0.952 0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system
0.048 0.952 0.000
T46.8 Antivaricose drugs, including sclerosing agents
0.048 0.952 0.000
T46.7 Peripheral vasodilators
0.048 0.952 0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action
0.048 0.952 0.000
T36.9 Systemic antibiotic, unspecified
0.048 0.952 0.000
T36.8 Other systemic antibiotics
0.048 0.952 0.000
T36.7 Antifungal antibiotics, systemically used
0.048 0.952 0.000
T36.6 Rifamycins
0.048 0.952 0.000
T36.5 Aminoglycosides
0.048 0.952 0.000
T36.3 Macrolides
0.048 0.952 0.000
T36.2 Chloramphenicol group
0.048 0.952 0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics
0.048 0.952 0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified
0.047 0.952 0.000
T39.4 Antirheumatics, not elsewhere classified
0.047 0.953 0.000
T39.2 Pyrazolone derivatives
0.047 0.953 0.000
F20.5 Residual schizophrenia
0.047 0.953 0.000
N87.0 Mild cervical dysplasia
0.047 0.953 0.000
T43.4 Butyrophenone and thioxanthene neuroleptics
0.047 0.953 0.000
I67.1 Cerebral aneurysm, nonruptured
0.000 0.954 0.046
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified
0.046 0.954 0.000
T46.1 Calcium-channel blockers
0.046 0.954 0.000
I61 Intracerebral haemorrhage
0.000 0.955 0.045
I67 Other cerebrovascular diseases
0.000 0.955 0.045
Chapter IV Endocrine, nutritional and metabolic diseases
0.000 0.956 0.044
I62 Other nontraumatic intracranial haemorrhage
0.000 0.956 0.044
T39.1 4-Aminophenol derivatives
0.044 0.956 0.000
T46.4 Angiotensin-converting-enzyme inhibitors
0.043 0.957 0.000
I61.9 Intracerebral haemorrhage, unspecified
0.000 0.957 0.043
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified
0.043 0.957 0.000
I62.0 Subdural haemorrhage (acute) (nontraumatic)
0.000 0.958 0.042
E70-E90 Metabolic disorders
0.000 0.958 0.042
T43.1 Monoamine-oxidase-inhibitor antidepressants
0.041 0.958 0.000
T36.0 Penicillins
0.041 0.958 0.000
T43.5 Other and unspecified antipsychotics and neuroleptics
0.041 0.959 0.000
I61.1 Intracerebral haemorrhage in hemisphere, cortical
0.000 0.959 0.041
T43.9 Psychotropic drug, unspecified
0.040 0.959 0.000
T43.8 Other psychotropic drugs, not elsewhere classified
0.040 0.959 0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified
0.040 0.960 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.000 0.960 0.040
T46.5 Other antihypertensive drugs, not elsewhere classified
0.039 0.960 0.000
I61.3 Intracerebral haemorrhage in brain stem
0.000 0.961 0.039
T43.0 Tricyclic and tetracyclic antidepressants
0.038 0.962 0.000
T43.6 Psychostimulants with abuse potential
0.037 0.963 0.000
I67.2 Cerebral atherosclerosis
0.000 0.963 0.037
E16 Other disorders of pancreatic internal secretion
0.000 0.963 0.037
I67.0 Dissection of cerebral arteries, nonruptured
0.000 0.963 0.037
T40.4 Other synthetic narcotics
0.037 0.963 0.000
T43.2 Other and unspecified antidepressants
0.036 0.964 0.000
T45.9 Primarily systemic and haematological agent, unspecified
0.036 0.964 0.000
T45.8 Other primarily systemic and haematological agents
0.036 0.964 0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants
0.036 0.964 0.000
T45.6 Fibrinolysis-affecting drugs
0.036 0.964 0.000
T45.4 Iron and its compounds
0.036 0.964 0.000
T45.3 Enzymes, not elsewhere classified
0.036 0.964 0.000
T45.0 Antiallergic and antiemetic drugs
0.036 0.964 0.000
I68 Cerebrovascular disorders in diseases classified elsewhere
0.000 0.964 0.035
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction
0.000 0.964 0.035
E85 Amyloidosis
0.000 0.965 0.035
E16.2 Hypoglycaemia, unspecified
0.000 0.965 0.035
T45.2 Vitamins, not elsewhere classified
0.034 0.965 0.000
E73 Lactose intolerance
0.000 0.966 0.034
Chapter V Mental and behavioural disorders
0.033 0.967 0.000
T45.1 Antineoplastic and immunosuppressive drugs
0.033 0.967 0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system
0.000 0.967 0.032
I67.5 Moyamoya disease
0.000 0.967 0.032
I67.4 Hypertensive encephalopathy
0.000 0.967 0.032
I67.3 Progressive vascular leukoencephalopathy
0.000 0.967 0.032
I67.7 Cerebral arteritis, not elsewhere classified
0.000 0.968 0.032
I61.4 Intracerebral haemorrhage in cerebellum
0.000 0.968 0.031
F60-F69 Disorders of adult personality and behaviour
0.031 0.969 0.000
I61.6 Intracerebral haemorrhage, multiple localised
0.000 0.970 0.030
E77 Disorders of glycoprotein metabolism
0.000 0.970 0.030
E76 Disorders of glycosaminoglycan metabolism
0.000 0.970 0.030
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.000 0.970 0.030
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.000 0.970 0.030
I62.1 Nontraumatic extradural haemorrhage
0.000 0.970 0.030
F60 Specific personality disorders
0.030 0.970 0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical
0.000 0.970 0.030
E16.0 Drug-induced hypoglycaemia without coma
0.000 0.970 0.029
E79 Disorders of purine and pyrimidine metabolism
0.000 0.971 0.029
E72 Other disorders of amino-acid metabolism
0.000 0.971 0.029
F60.9 Personality disorder, unspecified
0.029 0.971 0.000
I61.8 Other intracerebral haemorrhage
0.000 0.971 0.029
E15 Nondiabetic hypoglycaemic coma
0.000 0.971 0.029
F40-F48 Neurotic, stress-related and somatoform disorders
0.029 0.971 0.000
E73.9 Lactose intolerance, unspecified
0.000 0.972 0.028
E85.4 Organ-limited amyloidosis
0.000 0.972 0.028
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.000 0.972 0.028
I20-I25 Ischaemic heart diseases
0.000 0.972 0.028
I69 Sequelae of cerebrovascular disease
0.000 0.972 0.028
E70 Disorders of aromatic amino-acid metabolism
0.000 0.972 0.028
I61.5 Intracerebral haemorrhage, intraventricular
0.000 0.972 0.027
T45.5 Anticoagulants
0.027 0.972 0.000
I69.1 Sequelae of intracerebral haemorrhage
0.000 0.973 0.027
I61.2 Intracerebral haemorrhage in hemisphere, unspecified
0.000 0.973 0.027
I66.0 Occlusion and stenosis of middle cerebral artery
0.000 0.973 0.027
E85.9 Amyloidosis, unspecified
0.000 0.973 0.027
E16.9 Disorder of pancreatic internal secretion, unspecified
0.000 0.973 0.027
E16.8 Other specified disorders of pancreatic internal secretion
0.000 0.973 0.027
E16.4 Abnormal secretion of gastrin
0.000 0.973 0.027
E16.3 Increased secretion of glucagon
0.000 0.973 0.027
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors
0.027 0.973 0.000
I63 Cerebral infarction
0.000 0.973 0.027
F99-F99 Unspecified mental disorder
0.027 0.973 0.000
E85.3 Secondary systemic amyloidosis
0.000 0.973 0.026
E84 Cystic fibrosis
0.000 0.974 0.026
E88 Other metabolic disorders
0.000 0.974 0.026
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries
0.000 0.974 0.026
F70-F79 Mental retardation
0.026 0.974 0.000
I68.0 Cerebral amyloid angiopathy
0.000 0.974 0.026
I68.8 Other cerebrovascular disorders in diseases classified elsewhere
0.000 0.974 0.026
I68.2 Cerebral arteritis in other diseases classified elsewhere
0.000 0.974 0.026
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere
0.000 0.974 0.026
I66.8 Occlusion and stenosis of other cerebral artery
0.000 0.974 0.026
I66.2 Occlusion and stenosis of posterior cerebral artery
0.000 0.974 0.026
I66.1 Occlusion and stenosis of anterior cerebral artery
0.000 0.974 0.026
T43.3 Phenothiazine antipsychotics and neuroleptics
0.025 0.974 0.000
E85.8 Other amyloidosis
0.000 0.975 0.025
E85.2 Heredofamilial amyloidosis, unspecified
0.000 0.975 0.025
E85.1 Neuropathic heredofamilial amyloidosis
0.000 0.975 0.025
E85.0 Nonneuropathic heredofamilial amyloidosis
0.000 0.975 0.025
I62.9 Intracranial haemorrhage (nontraumatic), unspecified
0.000 0.975 0.025
T39.0 Salicylates
0.025 0.975 0.000
F69 Unspecified disorder of adult personality and behaviour
0.025 0.975 0.000
F45 Somatoform disorders
0.025 0.975 0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.025 0.975 0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery
0.000 0.975 0.025
I66.3 Occlusion and stenosis of cerebellar arteries
0.000 0.975 0.025
E73.8 Other lactose intolerance
0.000 0.975 0.025
E73.1 Secondary lactase deficiency
0.000 0.975 0.025
E73.0 Congenital lactase deficiency
0.000 0.975 0.025
E16.1 Other hypoglycaemia
0.000 0.975 0.024
E74 Other disorders of carbohydrate metabolism
0.000 0.976 0.024
F44 Dissociative [conversion] disorders
0.024 0.976 0.000
E80 Disorders of porphyrin and bilirubin metabolism
0.000 0.976 0.024
F60.2 Dissocial personality disorder
0.024 0.976 0.000
F60.8 Other specific personality disorders
0.024 0.976 0.000
F48 Other neurotic disorders
0.023 0.977 0.000
F60.7 Dependent personality disorder
0.023 0.977 0.000
E40-E46 Malnutrition
0.000 0.977 0.023
F80-F89 Disorders of psychological development
0.023 0.977 0.000
I63.8 Other cerebral infarction
0.000 0.978 0.022
F68 Other disorders of adult personality and behaviour
0.022 0.978 0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation
0.022 0.978 0.000
F65 Disorders of sexual preference
0.022 0.978 0.000
F63 Habit and impulse disorders
0.022 0.978 0.000
F61 Mixed and other personality disorders
0.022 0.978 0.000
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
0.000 0.978 0.022
F60.0 Paranoid personality disorder
0.022 0.978 0.000
E71.3 Disorders of fatty-acid metabolism
0.000 0.978 0.022
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified
0.000 0.978 0.022
E71.1 Other disorders of branched-chain amino-acid metabolism
0.000 0.978 0.022
E71.0 Maple-syrup-urine disease
0.000 0.978 0.022
E76.9 Disorder of glucosaminoglycan metabolism, unspecified
0.000 0.978 0.022
E76.8 Other disorders of glucosaminoglycan metabolism
0.000 0.978 0.022
E76.3 Mucopolysaccharidosis, unspecified
0.000 0.978 0.022
E76.2 Other mucopolysaccharidoses
0.000 0.978 0.022
E76.1 Mucopolysaccharidosis, type II
0.000 0.978 0.022
E76.0 Mucopolysaccharidosis, type I
0.000 0.978 0.022
E77.9 Disorder of glycoprotein metabolism, unspecified
0.000 0.978 0.022
E77.8 Other disorders of glycoprotein metabolism
0.000 0.978 0.022
E77.1 Defects in glycoprotein degradation
0.000 0.978 0.022
E77.0 Defects in posttranslational modification of lysosomal enzymes
0.000 0.978 0.022
I20.9 Angina pectoris, unspecified
0.000 0.978 0.022
F99 Mental disorder, not otherwise specified
0.022 0.978 0.000
F42 Obsessive-compulsive disorder
0.022 0.978 0.000
F40 Phobic anxiety disorders
0.022 0.978 0.000
F51 Nonorganic sleep disorders
0.022 0.978 0.000
F60.4 Histrionic personality disorder
0.022 0.978 0.000
F60.1 Schizoid personality disorder
0.022 0.978 0.000
F62 Enduring personality changes, not attributable to brain damage and disease
0.021 0.978 0.000
F60.5 Anankastic personality disorder
0.021 0.978 0.000
E75.5 Other lipid storage disorders
0.000 0.979 0.021
E79.9 Disorder of purine and pyrimidine metabolism, unspecified
0.000 0.979 0.021
E79.8 Other disorders of purine and pyrimidine metabolism
0.000 0.979 0.021
E79.1 Lesch-Nyhan syndrome
0.000 0.979 0.021
E72.9 Disorder of amino-acid metabolism, unspecified
0.000 0.979 0.021
E72.8 Other specified disorders of amino-acid metabolism
0.000 0.979 0.021
E72.5 Disorders of glycine metabolism
0.000 0.979 0.021
E72.4 Disorders of ornithine metabolism
0.000 0.979 0.021
E72.3 Disorders of lysine and hydroxylysine metabolism
0.000 0.979 0.021
E72.2 Disorders of urea cycle metabolism
0.000 0.979 0.021
E72.1 Disorders of sulphur-bearing amino-acid metabolism
0.000 0.979 0.021
F60.6 Anxious [avoidant] personality disorder
0.021 0.979 0.000
N87 Dysplasia of cervix uteri
0.021 0.979 0.000
F45.9 Somatoform disorder, unspecified
0.021 0.979 0.000
F79 Unspecified mental retardation
0.021 0.979 0.000
E80.6 Other disorders of bilirubin metabolism
0.000 0.979 0.020
F44.9 Dissociative [conversion] disorder, unspecified
0.021 0.979 0.000
I69.0 Sequelae of subarachnoid haemorrhage
0.000 0.979 0.021
F45.0 Somatisation disorder
0.020 0.980 0.000
E75.6 Lipid storage disorder, unspecified
0.000 0.980 0.020
E75.4 Neuronal ceroid lipofuscinosis
0.000 0.980 0.020
E75.3 Sphingolipidosis, unspecified
0.000 0.980 0.020
E75.1 Other gangliosidosis
0.000 0.980 0.020
E75.0 GM2 gangliosidosis
0.000 0.980 0.020
I20 Angina pectoris
0.000 0.980 0.020
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified
0.000 0.980 0.020
E70.9 Disorder of aromatic amino-acid metabolism, unspecified
0.000 0.980 0.020
E70.8 Other disorders of aromatic amino-acid metabolism
0.000 0.980 0.020
E70.2 Disorders of tyrosine metabolism
0.000 0.980 0.020
E70.1 Other hyperphenylalaninaemias
0.000 0.980 0.020
E70.0 Classical phenylketonuria
0.000 0.980 0.020
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease
0.000 0.980 0.020
F50 Eating disorders
0.020 0.980 0.000
F44.0 Dissociative amnesia
0.020 0.980 0.000
E72.0 Disorders of amino-acid transport
0.000 0.980 0.020
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified
0.020 0.980 0.000
E88.1 Lipodystrophy, not elsewhere classified
0.000 0.980 0.020
F81 Specific developmental disorders of scholastic skills
0.019 0.980 0.000
E88.9 Metabolic disorder, unspecified
0.000 0.980 0.019
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors
0.019 0.980 0.000
F55 Abuse of non-dependence-producing substances
0.019 0.980 0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere
0.019 0.980 0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
0.000 0.981 0.019
I63.1 Cerebral infarction due to embolism of precerebral arteries
0.000 0.981 0.019
F48.0 Neurasthenia
0.019 0.981 0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries
0.000 0.981 0.019
E84.8 Cystic fibrosis with other manifestations
0.000 0.981 0.019
E84.1 Cystic fibrosis with intestinal manifestations
0.000 0.981 0.019
E84.0 Cystic fibrosis with pulmonary manifestations
0.000 0.981 0.019
I23 Certain current complications following acute myocardial infarction
0.000 0.981 0.019
I24 Other acute ischaemic heart diseases
0.000 0.981 0.019
F78 Other mental retardation
0.019 0.981 0.000
F73 Profound mental retardation
0.019 0.981 0.000
F72 Severe mental retardation
0.019 0.981 0.000
F71 Moderate mental retardation
0.019 0.981 0.000
F70 Mild mental retardation
0.019 0.981 0.000
F44.4 Dissociative motor disorders
0.019 0.981 0.000
F52 Sexual dysfunction, not caused by organic disorder or disease
0.019 0.981 0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
0.019 0.981 0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage
0.000 0.981 0.019
F40.0 Agoraphobia
0.019 0.981 0.000
F45.4 Persistent somatoform pain disorder
0.019 0.981 0.000
F45.3 Somatoform autonomic dysfunction
0.019 0.981 0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction
0.000 0.981 0.018
I63.0 Cerebral infarction due to thrombosis of precerebral arteries
0.000 0.982 0.018
E88.3 Tumour lysis syndrome
0.000 0.982 0.018
F45.1 Undifferentiated somatoform disorder
0.018 0.982 0.000
F95 Tic disorders
0.018 0.982 0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence
0.018 0.982 0.000
F93 Emotional disorders with onset specific to childhood
0.018 0.982 0.000
F92 Mixed disorders of conduct and emotions
0.018 0.982 0.000
F91 Conduct disorders
0.018 0.982 0.000
F90 Hyperkinetic disorders
0.018 0.982 0.000
F45.8 Other somatoform disorders
0.018 0.982 0.000
F64 Gender identity disorders
0.018 0.982 0.000
F51.0 Nonorganic insomnia
0.018 0.982 0.000
I24.8 Other forms of acute ischaemic heart disease
0.000 0.982 0.018
E74.9 Disorder of carbohydrate metabolism, unspecified
0.000 0.982 0.017
E74.8 Other specified disorders of carbohydrate metabolism
0.000 0.982 0.017
E74.4 Disorders of pyruvate metabolism and gluconeogenesis
0.000 0.982 0.017
E74.2 Disorders of galactose metabolism
0.000 0.982 0.017
E74.1 Disorders of fructose metabolism
0.000 0.982 0.017
E74.0 Glycogen storage disease
0.000 0.982 0.017
F44.8 Other dissociative [conversion] disorders
0.018 0.982 0.000
F44.7 Mixed dissociative [conversion] disorders
0.018 0.982 0.000
F44.6 Dissociative anaesthesia and sensory loss
0.018 0.982 0.000
F44.3 Trance and possession disorders
0.018 0.982 0.000
F44.2 Dissociative stupor
0.018 0.982 0.000
F44.1 Dissociative fugue
0.018 0.982 0.000
N87.2 Severe cervical dysplasia, not elsewhere classified
0.018 0.982 0.000
E80.7 Disorder of bilirubin metabolism, unspecified
0.000 0.982 0.017
E80.5 Crigler-Najjar syndrome
0.000 0.982 0.017
E80.3 Defects of catalase and peroxydase
0.000 0.982 0.017
E80.2 Other porphyria
0.000 0.982 0.017
E80.0 Hereditary erythropoietic porphyria
0.000 0.982 0.017
E70.3 Albinism
0.000 0.982 0.017
N87.1 Moderate cervical dysplasia
0.017 0.983 0.000
F60.3 Emotionally unstable personality disorder
0.017 0.983 0.000
I63.9 Cerebral infarction, unspecified
0.000 0.983 0.017
I69.8 Sequelae of other and unspecified cerebrovascular diseases
0.000 0.983 0.017

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.